Internal Medicine, Endocrinology, Diabetes, & Metabolism · Montgomery, AL
NPI
1215215389
Since 2011
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2119 E South Blvd, Suite 200
Montgomery, AL, 36116
Phone (334) 613-7070
Groups this clinician bills Medicare through
Medicare paid, 2024
$48K
1,419 services
Medicare patients, 2024
281
Average age 72
Drug cost, 2024
$2.9M
4,849 prescriptions
Company payments, 2025
$1,046
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Manisha Garg was code 99214 (office e&m - established), 417 times for 240 patients. In total Manisha Garg billed 1,419 services in 11 codes, and Medicare paid $48K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 417 | 240 | $80.94 | $34K |
| 82962 Clinical Chemistry | Office | 310 | 165 | $3.12 | $967 |
| 83036 Blood Count | Office | 287 | 161 | $9.18 | $2,635 |
| 95251 Test - Miscellaneous | Office | 181 | 95 | $23.53 | $4,260 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 162 | 120 | $11.57 | $1,875 |
| 99204 Office E&M - New | Office | 28 | 28 | $90.42 | $2,532 |
| 99213 Office E&M - Established | Office | 28 | 26 | $63.70 | $1,784 |
By year: 2022 $56K for 1,717 services; 2023 $53K for 1,482 services; 2024 $48K for 1,419 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 310 | 165 | $3.12 | $967 |
| 83036 Blood Count | 287 | 161 | $9.18 | $2,635 |
Medicare prescription drug claims, 2024
In 2024, the drug Manisha Garg prescribed most often to Medicare patients was Levothyroxine Sodium, with 508 prescriptions and refills. In total Manisha Garg wrote 4,849 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 508 | 1,482 | 152 | $8,860 |
| Ozempic Semaglutide | 417 | 644 | 99 | $608K |
| Mounjaro Tirzepatide | 370 | 531 | 75 | $571K |
| Metformin Hcl Generic | 242 | 684 | 73 | $2,525 |
| Jardiance Empagliflozin | 178 | 340 | 49 | $201K |
| Synthroid Levothyroxine Sodium | 156 | 403 | 46 | $18K |
| Methimazole Generic | 132 | 344 | 34 | $1,772 |
| Trulicity Dulaglutide | 127 | 186 | 30 | $185K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 126 | 302 | 57 | $19K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 111 | 255 | 40 | $17K |
| Tresiba Flextouch U-200 Insulin Degludec | 109 | 209 | 27 | $99K |
| Januvia Sitagliptin Phosphate | 99 | 173 | 24 | $92K |
| Glipizide Generic | 92 | 269 | 29 | $900 |
| Metformin Hcl Er Metformin Hcl | 92 | 239 | 27 | $1,635 |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 87 | 207 | 29 | $64K |
Brand drugs: 3,066 claims; generic drugs: 1,332 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Manisha Garg $1,046 ($1,046 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbott Laboratories with $148.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 9 | $148 |
| Novo Nordisk Inc NVO | 6 | $123 |
| Tandem Diabetes Care, Inc. TNDM | 4 | $118 |
| Xeris Pharmaceuticals, Inc. | 5 | $110 |
| Beta Bionics, Inc. BBNX | 4 | $77.49 |
| Lilly USA, LLC LLY | 4 | $76.49 |
| Amneal Pharmaceuticals LLC AMRX | 4 | $59.7 |
| Mannkind Corporation MNKD | 2 | $54.65 |
| Medtronic, Inc. MDT | 2 | $53.77 |
| Ascendis Pharma Endocrinology Inc ASND | 2 | $39.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.